Ovarian cancer during pregnancy: clinical and pregnancy outcome.

Journal of Korean Medical Science
Yong-Soon KwonJae-Uk Shim

Abstract

The aim of this study is to evaluate the clinical feature and pregnancy outcome in patients with ovarian cancer diagnosed during pregnancy. We retrospectively analyzed the medical records of 27 patients diagnosed with ovarian cancer during pregnancy at Cheil General Hospital & Women's Healthcare Center from January 1996 to December 2006. Mean age of the patients was 29.1 yr (range 23-40), and a mean follow-up period was 57 months (range 7-112 months). Of 27 patients, 15 (55.5%) had borderline malignancies, 7 (25.9%) had epithelial malignancies and 5 (18.6%) had germ cell tumors. A total of 26 patients received a conservative surgery preserving pregnancy. The mean time for surgical intervention during pregnancy was 20 weeks of gestational age. Of the 27 patients, 26 had full term delivery of a healthy baby without any congenital malformation. Only one patient with epithelial ovarian cancer had a relapse at 19 months after the first conservative operation with adjuvant chemotherapy. There were few data for managing patients with ovarian cancer diagnosed during pregnancy. This study results could help establish a guideline for management of ovarian malignancy complicating pregnancy.

References

Mar 1, 1992·Archives of Internal Medicine·D ZemlickisG Koren
May 1, 1991·Gynecologic Oncology·S M FarahmandM R Dewey
Jun 1, 1986·British Journal of Obstetrics and Gynaecology·P Hogston, R J Lilford
Feb 1, 1995·The Surgical Clinics of North America·E C Grendys, W A Barnes
Oct 1, 1996·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·M Ueda, M Ueki
Jul 20, 1999·American Journal of Obstetrics and Gynecology·M P WhitecarM K Higby
Apr 18, 2000·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Y N Bakri Zahrani
Dec 6, 2001·Gynecologic Oncology·A K SoodJ I Sorosky
Feb 13, 2003·Archives of Gynecology and Obstetrics·Nutun AgarwalAnjali Gupta
May 10, 2003·Fertility and Sterility·Jacques DonnezJean Squifflet
Feb 1, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·X Y ZhaoJ H Lang
Jan 22, 2008·BMC Pregnancy and Childbirth·Nadereh BehtashFahimeh Ghotbizadeh

❮ Previous
Next ❯

Citations

Jan 28, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Donata GrimmSven Mahner
May 11, 2013·Case Reports in Obstetrics and Gynecology·Joao CasanovaRosa Maria Rodrigues
Feb 22, 2016·Archives of Gynecology and Obstetrics·Michiko KodamaKoji Matsuo
Aug 30, 2011·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Kazım GezginçMetin Capar
Dec 29, 2015·Best Practice & Research. Clinical Obstetrics & Gynaecology·Asima MukhopadhyayRaj Naik
Aug 2, 2012·Birth Defects Research. Part A, Clinical and Molecular Teratology·Brady P SeligJohn J Mulvihill
Feb 11, 2015·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Erin A BlakeKoji Matsuo
Oct 16, 2018·Minerva ginecologica·Stella CapriglioneSalvatore Lopez
Oct 4, 2017·BMC Pregnancy and Childbirth·Kathleen MelanClarisse Joachim
Dec 20, 2020·Cancers·Dominik Franciszek DłuskiBożena Leszczyńska-Gorzelak

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
cesarean section
hysterectomy
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Gynecologic Oncology
Gary S LeiserowitzLloyd H Smith
Gynecologic Oncology
Francisco MachadoLorenzo Abad
Archives of Gynecology and Obstetrics
Nutun AgarwalAnjali Gupta
Critical Reviews in Oncology/hematology
V J Wiebe, P E Sipila
© 2021 Meta ULC. All rights reserved